The Bionow Pharma Manufacturing Conference is a one-day conference addressing the needs and requirements of pharma manufacturers who compete on the global stage.
The conference will explore the challenges and enablers for pharma manufacturing in the North and start a conversation through which the Northern manufacturing sites begin to collaborate on areas of common interest and to better influence academia and Government industrial strategy to support manufacturing in this sector.
We are delighted that Ben Houchen, Mayor of Tees Valley will be opening the conference and Andrew Dwyer, Head of Clinical Packaging Operations at GlaxoSmithKline and Andy Topping, Chief Scientific Officer at Fujifilm Diosynth will be giving the Keynote Speeches.
Speakers from ARCINOVA, Fujifilm Diosynth, Iksuda Therapeutics, Elanco, Durham University, NEPIC, Teva, Northern Life Sciences, GlaxoSmithKline, Allergan Biologics, Siemens and Deloitte confirmed.
The conference will feature sessions on:
Ben Houchen, Mayor, Tees Valley
Andy Dwyer, Head of Clinical Packaging Operations, GlaxoSmithKline
Alfredo Ramos Plascenia, Healthcare Director, Centre for Process Innovation
Ian Shott, CEO, Arcinova
Rebecca Street-Howard, Quality Technical Manager, GlaxoSmithKline
Andy Whytock, Head of Digitalisation & Innovation, Siemens
David Twohig, Global Consultancy Group (Manufacturing IT Strategies - Life Science) at Enterprise System Partners Limited
Daniel Smith, Chief Scientific Officer, Cobra Biologics
Jenny Thirlway, Senior Director - Development Program Team Leader, Iksuda Therapeutics
Nick Martin, Vice Presdient of Operations, Fujifilm Diosynth
Alison Dorward, Fermentation Scientist, Elanco
Simon Beaumont, Assistant Professor in Chemistry, Durham University
Ian Anderson, Senior Manager - Analytical Sciences, Allergan Biologics
Julia Leach, Senior Scientist - Analytical, Centre for Process Innovation
Andy Topping, Chief Scientific Officer, Fujifilm Diosynth Biotechnologies
Gill Hall, Partner, Square One Law
Alan Dickson, Director, Centre of Excellence in Biopharmaceuticals
Ian Shott, CEO, Arcinova
Paul Irving, Managing Director, Northern Life Sciences
Karen Taylor, Director - UK Centre for Health Solutions, Deloitte
Linda Randall, Executive Director - Biologics Development, Allergan Biologics
Deborah Hatton, Training Manager, Teva
Fungayi Chidothe, Head of Strategy & Planning, Cell and Gene Therapy Catapult
Shirley Marshall, Principal Lecturer, Teesside University
Mike Devey, Apprentice, Allergan Biologics
Ben Gay, Apprentice, Centre for Process Innovation
Premium Member: £100.00 + VAT
Member: £150.00 + VAT
Non-Member: £200.00 + VAT
There is no better way to showcase new developments, ongoing projects and innovative work to industry experts, regulators and leading pharma manufacturers. Authors are invited to submit an abstract which is closely related to the area of pharma manufacturing.
The posters are intended to provide authors and participants with a greater understanding of the subject matter and to engage in discussions about the work.
Further details are available below:
Call for Posters.pdf